National HealthCare Corporation
AMEX:NHCMedical - Care Facilities
+$1.33 today
- Market cap
- $3.16B
- Beta
- 0.67
- P/E (TTM)
- 24.2
- EPS (TTM)
- $7.96
- Dividend yield
- 1.33%
Volume 0.10M
Average 0.12M
NHC Net Income
Bottom-line profit after all expenses, interest, and taxes.
National HealthCare CorporationAMEX: NHC
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income dips below year-ago levels
Q3 FY2026 net income of $13.64M fell 65.2% year over year, behind the +13.2% change in trailing-twelve-month net income. Sequentially, it fell 66.2% from the prior quarter. Over 3 fiscal years it compounded at +74.9% a year.
Context
- Net income amounted to 7.9% of revenue in FY2025, unchanged from a year earlier.
- Net income increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -65.2% toward the trailing-twelve-month pace of +13.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Net Income history
USD · from the income statement
- Latest · FY2025
- 120.02M USD
- Year-over-year change
- +17.7%
- 4-year CAGR
- -3.5%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 120.02M | +17.7% |
| FY2024 | 2024-12-31 | 101.93M | +52.6% |
| FY2023 | 2023-12-31 | 66.8M | +197.6% |
| FY2022 | 2022-12-31 | 22.45M | -83.8% |
| FY2021 | 2021-12-31 | 138.59M | — |
Net Income vs competitors
How NHC compares with its peers on the latest reported figures
- NHC's LTM Sep 2026 net income of $114.66M is the 5th highest of the 10 companies compared; the peer median is $105.31M.
- Its year-over-year change of +13.2% is the 8th highest of 10, against a peer median of +19.2%.
- Net income amounts to 7.2% of revenue for NHC, versus a peer median of 7.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $621M | +18.8% | +27.8% | 10.0% | |
| LTM Jun 2026 | $378.7M | +17.3% | +15.3% | 6.9% | |
| LTM Oct 2026 | $306.15M | +305.7% | — | 11.4% | |
| LTM Jun 2026 | $274.99M | -5.3% | +2.0% | 10.6% | |
| LTM Sep 2026 | $114.66M | +13.2% | +74.9% | 7.2% | |
| LTM Jun 2026 | $105.31M | +26.9% | +27.7% | 7.1% | |
| LTM Mar 2026 | $30.32M | +19.2% | +64.5% | 3.0% | |
| LTM Mar 2026 | -$22.2M | +28.9% | — | 2.3% | |
| LTM Sep 2026 | -$37.49M | +87.8% | — | 1.3% | |
| LTM Mar 2026 | -$99.48M | -139.1% | — | 24.2% | |
| Peer median (excluding NHC) | $105.31M | +19.2% | +27.7% | 7.1% | |
Competitors are the stored peer set for NHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.01B | 1.07B | 1.14B | 1.3B | 1.52B |
| Cost of Revenue | 666.06M | 686.17M | 712.34M | 810.93M | 921.08M |
| Gross Profit | 344.88M | 388.11M | 429.2M | 487.01M | 596.7M |
| Gross Margin | 34.1% | 36.1% | 37.6% | 37.5% | 39.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 40.82M | 40.98M | 41.53M | 43.18M | 46.23M |
| Operating Expenses | 293.95M | 356.22M | 372.07M | 401.25M | 468.35M |
| Depreciation & Amortization | 40.67M | 40.49M | 42.03M | 41.99M | 44.92M |
| EBITDA | 191.56M | 68.28M | 131.1M | 182.53M | 213.72M |
| EBITDA Margin | 18.9% | 6.4% | 11.5% | 14.1% | 14.1% |
| Operating Income | 50.93M | 31.9M | 57.13M | 85.76M | 128.35M |
| Operating Margin | 5.0% | 3.0% | 5.0% | 6.6% | 8.5% |
| Interest Income | 4.67M | 5.13M | 8.38M | 10.1M | 9.84M |
| Interest Expense | 845K | 563K | 324K | 4.14M | 6.37M |
| Other Income / Expenses | 99.11M | (4.67M) | 31.6M | 50.65M | 34.08M |
| Income Before Tax | 150.04M | 27.23M | 88.74M | 136.41M | 162.43M |
| Pre-Tax Margin | 14.8% | 2.5% | 7.8% | 10.5% | 10.7% |
| Income Tax Expense | 10.95M | 7.25M | 23.45M | 34.32M | 39.83M |
| Net Income | 138.59M | 22.45M | 66.8M | 101.93M | 120.02M |
| Net Margin | 13.7% | 2.1% | 5.9% | 7.9% | 7.9% |
| EPS (Basic) | 9.03 | 1.46 | 4.36 | 6.62 | 7.76 |
| EPS (Diluted) | 8.99 | 1.45 | 4.34 | 6.53 | 7.67 |
| Weighted Avg Shares | 15.35M | 15.41M | 15.31M | 15.39M | 15.47M |
| Weighted Avg Shares (Diluted) | 15.42M | 15.45M | 15.38M | 15.6M | 15.65M |
National HealthCare Corporation
AMEX:NHC
Intrinsic Alpha fair value
Locked
Current Price
$201.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.